COVID-19 significantly increases the risk of major adverse cardiac events (MACE) like heart attacks and strokes, especially in hospitalized patients, with a risk of MACE more than double that of the general population.
Data from the UK Biobank study analyzed over 10,000 COVID-19 cases, revealing that hospitalization poses an even greater risk for MACE than existing cardiovascular disease.
Genetic factors, such as blood type, influence the severity of these risks, with non-O blood types showing a higher likelihood of thrombotic events compared to O blood types.